Pablo
Díaz-Kruik
and
Francesca
Paradisi
*
Department of Chemistry, Biochemistry and Pharmacology, University of Bern, Freistrasse 3, Bern, Switzerland. E-mail: francesca.paradisi@unibe.ch
First published on 23rd January 2024
Local anaesthetics such as mepivacaine are key molecules in the medical sector, so ensuring their supply chain is crucial for every health care system. Rapid production of mepivacaine from readily available commercial reagents and (non-dry) solvents under safe conditions using portable, continuous apparatus could make an impactful difference in underdeveloped countries. In this work, we report a continuous platform for synthesising mepivacaine, one of the most widely used anaesthetics for minor surgeries. With a focus on sustainability, reaction efficiency and seamless implementation, this platform afforded the drug in 44% isolated yield following a concomitant distillation–crystallisation on a gram scale after N-functionalisation and amide coupling, with full recovery of the solvents and excess reagents. The use of flow chemistry as an enabling tool allowed the use of “forbidden” chemistry which is typically challenging for preparative and large scale reactions in batch mode. Overall, this continuous platform presents a promising and sustainable approach that has the potential to meet the demands of the healthcare industry.
Mepivacaine and its derivatives such as ropivacaine and bupivacaine are among the most used agents in orthopaedic regional anaesthesia for lower limb surgeries as well as in oral and maxillofacial surgeries.4–6 Scarily, this is not the case in underdeveloped countries, where the use of local anaesthetics is not the standard practice for a variety of reasons such as the lack of medical training, availability of medications, storage, etc.7,8 The COVID-19 pandemic in 2020 has also highlighted in wealthy countries the critical need to establish autonomous chemical production of pharmaceuticals and chemicals to avoid supply chain shortages. Anaesthetics and sedatives, which are generally simple chemical structures, became extremely scarce in the pandemic,9,10 with the unprecedentedly high demand worldwide further aggravated by the disruption in production (and export) in India and China where a large percentage of raw ingredients are produced.11–13
To achieve rapid relocalisation of production, flow chemistry emerges as a key technology in this transition. Its intrinsic modularity and fast implementation set it apart from classical batch synthesis that usually requires large facilities.
Several methods (Fig. 1) for the synthesis of these types of molecules have been described in the literature, first by Ekenstam et al. in 1956 and sixty years later by Suveges et al. in 2017.1,14 Generally, the first step is an amide coupling reaction between the aromatic picolinic acid 1a and 2 either via an acyl chloride intermediate or by using coupling reagents such as EDC/HOBt and DCC,15,16 and the second step is usually a palladium mediated hydrogenation to reduce the aromatic compound, followed by the alkylation of the pyrimidine nitrogen with a suitable alkylating reagent. Even though this strategy is efficient (85–95% crude isolated yields), it poses obvious environmental and operational risks on higher scales due to the handling of toxic reagents such as thionyl chloride, phosphorus pentachloride, and alkylating reagents that are well known to be potentially carcinogenic.17,18 In addition, from a process chemistry perspective the synthesis itself has several challenges: formation of the acyl chloride is an exothermic reaction that generates HCl(g) and needs to be carefully controlled; otherwise, the risk of a runaway scenario could have fatal consequences.
In 2017, Suveges et al.14 redesigned the synthesis of these analogues, overcoming some of the risks and limitations of the previous strategies. In this case, the authors managed to spare one synthetic step by performing at the same time the hydrogenation and the N-alkylation via a reductive amination strategy, avoiding the use of toxic alkylating reagents. By taking advantage of a flow setup, they successfully used the same heterogeneous catalyst (10% Pd/C) and reducing agent (H2(g)) for both reactions, overcoming reagent toxicity and improving process safety. Nevertheless, this strategy still has some drawbacks such as the requirement of hydrogen (or hydrogen generators in situ such as an H-cube), generation of HCl(g) upon amide coupling and the need to use PCl3 as a chlorinating reagent, leading to the formation of large amounts of phosphorus-derived waste that is difficult to process,19 lowering in this way the atom economy and greenness of the overall synthesis. In addition, the transposition to flow of the first step was not attempted due to the formation of precipitates that could lead to reactor clogging.
Here we present a continuous system which enables for the first time the rapid synthesis of these molecules which can be run in a completely automated manner, showcasing a safer and more sustainable alternative to the previously reported methods.
All reagents, under the tested conditions, successfully reduced the imine bond. However, NaBH3CN, despite being efficient, displays health and process risks on large scales since toxic HCN(g) could be released upon acidic workup; 2-picoline-borane is insoluble under the tested reaction conditions leading to potential clogging in a flow setup; finally the Eschweiler–Clarke21 reaction, which uses formic acid as a reducing agent, was found to be inefficient in terms of formic acid equivalents. Despite these limitations, the Eschweiler–Clarke approach has potential for a flow chemistry setup and it has been previously successfully applied to the continuous synthesis of dumetorine.22 Continuous flow apparatuses offer the possibility of working at temperatures higher than the boiling point of the solvent by controlling the pressure with a back-pressure regulator. Additionally, as all the reaction components and products are miscible, the risk of reactor fouling due to solid accumulation would be minimised. The first flow setup was therefore trialled (Scheme 2).
The first screening of the reaction conditions was performed in order to identify critical parameters (Tables S1–S4, ESI†). Residence time, formic acid equivalents, and reactor temperature were found to be crucial to achieve full conversion (entries 3 and 5, Table 2).
Entry | Molar ratio (pipecolic acid![]() ![]() |
Residence time (min) | Temperature (°C) | Conversion (%) |
---|---|---|---|---|
1 | 1![]() ![]() |
45 | 120 | 4 |
2 | 1![]() ![]() |
45 | 120 | 33 |
3 | 1![]() ![]() |
45 | 150 | >99 |
4 | 1![]() ![]() |
15 | 150 | 80 |
5 | 1![]() ![]() |
45 | 150 | >99 |
Once it was established that the system could efficiently perform under continuous flow, the second step of the multi-step synthesis, the amide coupling, was explored.
Recent papers describe more sustainable amide bond syntheses; for example, in the work by Brittain et al. in 2021,24 they generated in situ an acyl fluoride to activate the carbonyl group. Pentafluoropyridine (PFP) is more efficient in terms of atom economy and solvent choice (acetonitrile) than the classically used coupling reagents such as HATU or PyBOP. However, with our substrate (1c), this approach was unsuccessful even with less hindered amines (Table S5, ESI†).
We revised our initial strategy and considered the possibility of starting from the commercially available methyl pipecolinate (1b) rather than the free acid, as this offers more options in terms of amide coupling. We seamlessly adapted the reductive amination protocol to the ester substrate (Table S7, ESI†) and tested the efficiency of an acyl transferase we had successfully used on other sterically hindered systems.25,26 Disappointingly, this did not lead to any detectable product (Table S6, ESI†).
The Hevia group27 reported a fast and more sustainable strategy to produce amides starting from esters and in situ production of lithium amides in hexane (Scheme 3). They then replaced the widely used tetrahydrofuran (THF) with 2-methyltetrahydrofuran (2-MeTHF), a bio-derived solvent, for the coupling step.28,29 However, the requirements of pyrophoric reagents, cryogenic temperatures to control the exothermicity of the reaction, and dry and degassed solvents have so far limited the scalability of this system in batch. A continuous flow setup, with its highly efficient heat transfer and smaller reactor volumes, could offer a practical solution and could be tested with N-methylpipecolinate (4b).30–33
With our system, the use of hexane for the lithiation step (entries 1 and 2, Table 3) enabled such a reaction to be carried out at room temperature; however, the required solvent exchange from hexane to 2-MeTHF to carry out the coupling of the Li-amide with 4b appeared problematic for its transposition to flow. In batch, this is a straightforward task that only requires evaporation and subsequent solvent addition. In continuous flow, this is not possible; therefore, we tested the feasibility of the 2-step reaction in batch in a single solvent. For purely practical reasons, we screened different reaction conditions with available dry THF, with the intention of switching to the greener 2-MeTHF if the results were encouraging (2-MeTHF behaves virtually identical to THF in organometallic reactions requiring a strong Lewis base).29 The crude N-methylpipecolinate 4b (obtained in the previous step) could be easily redissolved in THF, but the use of THF as the sole solvent at room temperature for both lithiation and amide coupling was unsuccessful (entry 3, Table 3), leading to the deprotonation of THF and subsequent ring opening34 with significant heat generation. Lowering the temperature to −78 °C (entry 4, Table 3) showed no conversion after 2 h probably due to the low solubility of the reagents. In contrast, carrying out the deprotonation step at −78 °C and then allowing the reaction mixture to reach room temperature before amide coupling enabled the detection of the coupling product by 1H-NMR (entry 5, Table 3). Despite the poor efficiency of the reaction under the tested conditions and the requirement of a low temperature, the solubility was no longer an issue, and the reaction could be attempted in a flow setup.
Entry | Solvent used for deprotonation | Temperature for deprotonation (°C) | Li-amide (1 M) (eq.) in THF | Temperature (°C) for coupling reaction | Conversion (%), time |
---|---|---|---|---|---|
a 2-MeTHF was used in the coupling step. | |||||
1 | Hexane | 25 | 1.5 | 25 | >99, 20 s![]() |
2 | Hexane | 25 | 1.0 | 25 | >99, 20 s![]() |
3 | THF | 25 | 1.0 | 25 | n.d., 2 h |
4 | THF | −78 | 1.0 | −78 | n.d., 2 h |
5 | THF | −78 | 1.0 | 25 | Traces after 18 h |
To understand the behaviour of the reaction in flow, the system was decoupled into its two steps: Li-amide formation and amide coupling. To analyse the efficiency of the deprotonation step, this was carried out in flow followed by electrophilic quenching in batch using ethyl benzoate (4c) as a model substrate (Table S10 and Scheme S4, ESI†). To our surprise, this afforded the coupling product with excellent conversion at room temperature and with dry THF as the sole solvent within seconds. In flow, the heat exchange is highly favoured due to the decreased ratio between effective volume and heat exchange surface, leading to precise control of the reaction exothermicity.
We therefore telescoped both steps in continuous mode (Fig. 2), using first ethyl benzoate (4c) to optimise the conditions. 1.5 equivalents of Li-amide (5) to ester were found to be optimal, requiring just 10 seconds for the deprotonation step (entry 2, Table 4). The efficiency of mixing (higher conversion at shorter residence times, entries 2 and 3) is a crucial parameter in this very rapid process. The reaction was then tested with the crude pre-anaesthetic ester intermediate (4b) redissolved in dry THF. With this less activated substrate, increasing the residence time (Rt) from 6 to 12 seconds for the amide coupling step was sufficient to achieve full conversion (entries 4 and 5, Table 4).
The transposition of Hevia's amide synthesis to flow clearly offers a technological advantage compared to the batch method, which requires air-sensitive techniques to avoid the risks associated with pyrophoric and highly reactive reagents. Flow setups, being closed systems by nature, drastically improve the safety of this method. Moreover, the ability to perform this reaction at room temperature within the same solvent system opens the door to larger scale processes, as costly cryogenic setups can be avoided. Motivated by these results, we explored the possibility of further increasing and intensifying the overall multi-step synthesis of mepivacaine (7).
Three key parameters were targeted for the optimisation of the first step: reactor temperature, concentration of the ester (4b) and residence time. Increasing the concentration of the ester to 100 mM (entry 1, Table 5) and even to 1.6 M (entry 4, Table 5), which had never been attempted before, showed that the system performs as efficiently as that at the 10 mM scale with exceptional potential for process intensification. In turn, decreasing the reactor temperature lowered the conversion (Table S9, ESI†); therefore, this was maintained at 150 °C. The system could still achieve full conversion even with significantly less equivalents of formic acid and formaldehyde (reduced to only 3.3 and 3.0, respectively), in line with what was previously reported.22 This not only improved the global sustainability of the process, but also enabled a steady operation of the next step (the amide coupling). Paraformaldehyde is an impurity present in the commercially available solution of 37% formaldehyde, which in increased amounts causes reactor fouling. However, reducing the equivalents of formaldehyde to 3.0 eq. prevents this from happening.
Entry | [1b] (M) | Formaldehyde (eq.) | Formic acid (eq.) | Residence time (min) | Conversion (%) |
---|---|---|---|---|---|
1 | 0.10 | 27.9 | 2650 (neat) | 45 | >99 |
2 | 0.10 | 27.9 | 53 | 10 | >99 |
3 | 0.83 | 16.2 | 6.4 | 5 | >99 |
4 | 1.60 | 3.0 | 3.3 | 5 | >99 |
Once the reductive amination was optimised, the goal was to couple it with the amide bond formation, ideally in a fully telescoped and continuous manner. A main concern arose: is the amide formation step robust enough to work in wet organic solvents? 4b was in fact efficiently extracted from the aqueous reaction environment in 2-MeTHF and could be used directly in the coupling step. This aspect is particularly important for scalability and cost efficiency; however, published protocols indicate that solvents are dried, distilled, and degassed, and indeed this was also used in our initial screening discussed above. However, by simply increasing the residence time from 12 seconds to less than 4 minutes and the n-BuLi equivalents from 1.5 to 2, conversions up to 90% under these suboptimal (but more practical) conditions were obtained (Table S13, ESI†).
To prove the feasibility of the whole process (Fig. 3), a production campaign was run on a preparative scale: 7.2 grams (1.6 M) of pipecolic ester 1b were processed in 25 minutes with quantitative conversion and 93% crude yield of N-methylpipecolinate 4b. This was followed by a separate 16 min campaign to process 1.8 grams of the 4b intermediate, achieving in this step 90% conversion and 47% isolated yield of highly pure mepivacaine following a concomitant distillation–crystallisation procedure that allowed also the recovery of the unreacted amine as well as the 2-MeTHF used for the amide formation (Fig. 3). Given the 93% yield of the reductive amination, the platform afforded the anaesthetic (7) in 44% overall yield.
By following McElroy's recommendations to evaluate sustainability in the pharmaceutical industry,35 a detailed analysis of the individual steps and the whole process was performed (Table 6). Details of the calculations are given in the ESI.†
Metric | Reductive amination | Lithiation | Amide coupling | Overall process |
---|---|---|---|---|
a Corrected E-factor includes the water contribution. | ||||
Space time yield (STY) (kg (L h)−1) | 1.4 | 24.4 | 0.4 | 0.4 |
E factor (kg waste (kg product)−1) | 13.5 | 1.1 | 4.0 | 18.6 |
Corrected E factora (kg waste (kg product)−1) | 25.8 | 1.1 | 26.1 | 53.0 |
Process mass intensity (PMI) (kg total (kg product)−1) | 26.8 | 2.1 | 27.1 | 56.0 |
Atom economy (%) | 85 | 69 | 87 | 51 |
We were delighted to see not only that the overall process was efficient in terms of cumulative space time yield (0.4 kg (L h)−1) but also that the environmental impact (E-factor) of the process was significantly lower (18.6 kg waste (kg product)−1) than those of the average pharmaceutical processes (25–100 kg waste (kg product)−1).36 In classical calculations of the E factor, the contribution of water is generally not included.36 Here, we also reported for comparison the corrected E factors (including water) and the difference in values is significant, with the obvious exclusion of the lithiation step. For the individual steps, the calculations show where the process reaches the highest efficiency in terms of productivity (lithiation step) and where there is a bottleneck (amide coupling). The E-factor showed again that the lithiation step is the most efficient step also in terms of waste management, highlighting the importance of the unit operation and solvent choice in the process design which is, in most cases, one of the biggest contributors to the process waste. Although the E-factor is a reliable measure of the environmental impact of a process, it focuses only on waste generation rather than resource management. Thus, including the process mass intensity (PMI) allows a deeper understanding of the resource consumption and identification of potential improvements rather than focusing only on problem solving.37 In Fig. 4, a detailed analysis of the PMI of the process is shown; in most cases, the water and the solvents used in the individual steps were the main contributors to the global index (56.0 kg total materials (kg product)−1). Considering that the average PMI values for commercial phase drugs range between 120 and 170,38,39 our process clearly demonstrates an improved efficiency and sustainability already at an early development stage of the synthetic methodology. While a direct comparison of this metric with that of previous methodologies (Fig. 1) is challenging, we attempted the same analysis which shows that this synthetic approach is beneficial (see Table S14†). This metric is a better tool that goes beyond waste minimisation to include efficient management of the resources,40 since it allows for individually targeting in further process optimisation rounds.
Additionally, for each step, the atom economy (AE) of the synthesis was calculated. The synthesis design is clearly highly efficient with two out of the three steps having more than 85% of the atoms of the reagents incorporated into the final product (7). When assessing the sustainability of the whole platform not only the above parameters were considered but also the solvent choice. Here, 2-MeTHF, a bio-derived ether,41 replaced tetrahydrofuran (THF), a classical solvent used in organometallic chemistry. This choice could potentially prevent future fossil fuel shortages.
This multi-step continuous platform has proved to be more sustainable than the previously reported methods. Notably, the use of water as the exclusive solvent for the reductive amination step and formic acid as a reducing agent has eliminated the need for atom-inefficient reagents like 2-picoline-borane or the potentially hazardous sodium cyanoborohydride.
In the case of the amide coupling, the main advantage of using flow chemistry lies in the ability to re-open the chemical window of lithiation at room temperature, thanks to the excellent heat transfer in the tubular reactor. From a process chemistry perspective, the use of flow chemistry not only allows the reaction to occur at room temperature but also provides efficient control over the reaction exothermicity, thereby avoiding potential runaway scenarios on large scales. Even though a significant amount of material is involved, the effective volume engaged at any given time in the reactor is minimal compared to what would be required in batch mode.
The role of 2-MeTHF is not limited to making the synthesis more sustainable and avoiding intermediate solvent exchanges; it also plays a crucial role in the feasibility of the process, minimising reactor fouling. 2-MeTHF not only readily extracts the N-methylated ester from the aqueous reaction environment, but it can also solubilise LiOH which is known to cause clogging issues when handling organometallics in flow.
While we have reported here a telescoped approach between the first and second step of this cascade, the extraction of N-methylpipecolinate is carried out manually due to the limitations of our flow system (Scheme S6†), and this could be clearly done in an automated manner with more advanced equipment.
Our current work focuses on expanding this methodology to the whole range of this class of anaesthetics and on the automation of the unit operation. Additionally, efforts are being made to explore large scale implementation of the process.
To summarise, we have demonstrated a new and highly sustainable synthetic platform for the synthesis of the local anaesthetic mepivacaine (7). Given the modularity of the flow setup, this could be extended to the synthesis of the rest of the caine family such as bupivacaine, lidocaine, ropivacaine, etc., which also contain the amide core in their structures,14,42,43 demonstrating in this way the wide application range of our method.
Remarks: when the solvent used for the deprotonation and the coupling step is 2-MeTHF, the intermediate solvent removal is not performed.
Remarks: it is important to use fresh bottles of 37% formaldehyde to avoid substantial amounts of paraformaldehyde that may lead to clogging issues downstream.
Remarks: it is crucial to use fresh bottles of n-BuLi since they tend to have lower amounts of LiH which can potentially lead to reactor fouling. We also found that bottles from Across were cleaner in terms of solid particles than the ones from Sigma Aldrich.
Footnote |
† Electronic supplementary information (ESI) available. See DOI: https://doi.org/10.1039/d3gc04375d |
This journal is © The Royal Society of Chemistry 2024 |